Publications by authors named "D Bedard"

L-3,4-dihydroxyphenylalanine (L-DOPA) remains the main treatment for motor symptoms of Parkinson's disease (PD). However, chronic use is associated with the development of complications such as L-DOPA-induced dyskinesia. We previously demonstrated that LY-487,379, a highly selective metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulator (PAM), reduces the severity of L-DOPA-induced abnormal involuntary movements (AIMs) in the 6-hydroxydopamine (6-OHDA)-lesioned rat model of PD, without interfering with the anti-parkinsonian action of L-DOPA.

View Article and Find Full Text PDF

Background: Language and cultural discordance refer to when a physician and patient do not share the same language or culture. This can create barriers to providing high-quality care at the end-of-life (EoL). This study explores the intersections of language, culture, geography, and care model in EoL care from the perspectives of palliative care physicians.

View Article and Find Full Text PDF

We aimed to describe the characteristics of teachers' engagement and persistence in an innovative multidisciplinary health programme. Participants in this descriptive and comprehensive study consisted of teachers in higher education (veterinary medicine, human medicine, pharmacy, engineers in husbandry) who were involved in the conception and the implementation of an international Master programme called MAN-IMAL. This programme was characterized by interculturality, multidisciplinarity, using technology, active teaching, and learning.

View Article and Find Full Text PDF

Context: To tackle the systemic injustices experienced by people in vulnerable situations, occupational therapists' agency, i.e. their power to act, is necessary.

View Article and Find Full Text PDF
Article Synopsis
  • Activation of metabotropic glutamate 2 (mGlu) receptors shows promise as a new treatment for parkinsonism, with the positive allosteric modulator (PAM) LY-487,379 demonstrating effectiveness in primates.
  • The study tested a different mGlu PAM, BINA, and found that it significantly reduced parkinsonism symptoms in MPTP-lesioned marmosets, achieving comparable results to high doses of L-DOPA.
  • BINA not only decreased parkinsonism but also significantly reduced dyskinesia and psychosis-like behaviors, indicating that mGlu modulation could provide anti-parkinsonian benefits independent of specific chemical structures.
View Article and Find Full Text PDF